## Abstract Mutations in the dystrophin gene cause an Xβlinked genetic disorder: Duchenne muscular dystrophy (DMD). Stem cell therapy is an attractive method to treat DMD because a small number of cells are required to obtain a therapeutic effect. Here, we discussed about multiple types of myogenic
β¦ LIBER β¦
Cell therapy strategies and improvements for muscular dystrophy
β Scribed by Quattrocelli, M; Cassano, M; Crippa, S; Perini, I; Sampaolesi, M
- Book ID
- 109841222
- Publisher
- Nature Publishing Group
- Year
- 2009
- Tongue
- English
- Weight
- 422 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1350-9047
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cell based therapy for duchenne muscular
β
Andrea Farini; Paola Razini; Silvia Erratico; Yvan Torrente; Mirella Meregalli
π
Article
π
2009
π
John Wiley and Sons
π
English
β 159 KB
Hope for muscular dystrophy therapy
π
Article
π
1997
π
Elsevier Science
π
English
β 107 KB
The allure of stem cell therapy for musc
β
Miranda D. Grounds; Kay E. Davies
π
Article
π
2007
π
Elsevier Science
π
English
β 69 KB
Improved adenoviral vectors for gene the
β
M.A Hauser; A Amalfitano; R Kumar-Singh; S.D Hauschka; J.S Chamberlain
π
Article
π
1997
π
Elsevier Science
π
English
β 240 KB
Challenges: Cell transplantation and gen
β
Jennifer E. Morgan; Terence A. Partridge
π
Article
π
1992
π
John Wiley and Sons
π
English
β 666 KB
## Abstract Duchenne's muscular dystrophy (DMD), which affects 1/3500 live male births, involves a progressive degeneration of skeletal and cardiac muscle, leading to early death. The protein dystrophin is lacking in DMD and present, but defective, in the allelic, less severe, Becker muscular dystr
Anti-stress therapy for muscular dystrop
β
DeFrancesco, Laura
π
Article
π
2012
π
Nature Publishing Group
π
English
β 101 KB